Logo image of FRVIA.PA

FORVIA (FRVIA.PA) Stock Fundamental Analysis

EPA:FRVIA - Euronext Paris - Matif - FR0000121147 - Common Stock - Currency: EUR

9.304  -0.14 (-1.5%)

Fundamental Rating

3

Overall FRVIA gets a fundamental rating of 3 out of 10. We evaluated FRVIA against 30 industry peers in the Automobile Components industry. Both the profitability and financial health of FRVIA have multiple concerns. FRVIA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FRVIA was profitable.
FRVIA had a positive operating cash flow in the past year.
In the past 5 years FRVIA reported 4 times negative net income.
Each year in the past 5 years FRVIA had a positive operating cash flow.
FRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFFRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

FRVIA's Return On Assets of -0.61% is in line compared to the rest of the industry. FRVIA outperforms 43.33% of its industry peers.
FRVIA has a Return On Equity of -4.32%. This is in the lower half of the industry: FRVIA underperforms 66.67% of its industry peers.
With a Return On Invested Capital value of 5.12%, FRVIA perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
FRVIA had an Average Return On Invested Capital over the past 3 years of 4.67%. This is in line with the industry average of 6.39%.
The 3 year average ROIC (4.67%) for FRVIA is below the current ROIC(5.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.61%
ROE -4.32%
ROIC 5.12%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
FRVIA.PA Yearly ROA, ROE, ROICFRVIA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

FRVIA has a Operating Margin (4.56%) which is comparable to the rest of the industry.
FRVIA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 13.36%, FRVIA is doing worse than 83.33% of the companies in the same industry.
FRVIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.56%
PM (TTM) N/A
GM 13.36%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
FRVIA.PA Yearly Profit, Operating, Gross MarginsFRVIA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

FRVIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FRVIA has about the same amount of shares outstanding.
FRVIA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FRVIA has been reduced compared to a year ago.
FRVIA.PA Yearly Shares OutstandingFRVIA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
FRVIA.PA Yearly Total Debt VS Total AssetsFRVIA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

FRVIA has an Altman-Z score of 1.14. This is a bad value and indicates that FRVIA is not financially healthy and even has some risk of bankruptcy.
FRVIA has a Altman-Z score of 1.14. This is in the lower half of the industry: FRVIA underperforms 76.67% of its industry peers.
FRVIA has a debt to FCF ratio of 17.80. This is a negative value and a sign of low solvency as FRVIA would need 17.80 years to pay back of all of its debts.
FRVIA has a worse Debt to FCF ratio (17.80) than 63.33% of its industry peers.
A Debt/Equity ratio of 2.46 is on the high side and indicates that FRVIA has dependencies on debt financing.
With a Debt to Equity ratio value of 2.46, FRVIA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.46
Debt/FCF 17.8
Altman-Z 1.14
ROIC/WACC0.97
WACC5.26%
FRVIA.PA Yearly LT Debt VS Equity VS FCFFRVIA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.99 indicates that FRVIA may have some problems paying its short term obligations.
FRVIA's Current ratio of 0.99 is on the low side compared to the rest of the industry. FRVIA is outperformed by 76.67% of its industry peers.
A Quick Ratio of 0.80 indicates that FRVIA may have some problems paying its short term obligations.
FRVIA's Quick ratio of 0.80 is in line compared to the rest of the industry. FRVIA outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.8
FRVIA.PA Yearly Current Assets VS Current LiabilitesFRVIA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.55% over the past year.
Measured over the past years, FRVIA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.18% on average per year.
The Revenue has decreased by -1.01% in the past year.
Measured over the past years, FRVIA shows a quite strong growth in Revenue. The Revenue has been growing by 8.71% on average per year.
EPS 1Y (TTM)14.55%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%29.17%
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-1.37%

3.2 Future

Based on estimates for the next years, FRVIA will show a very strong growth in Earnings Per Share. The EPS will grow by 39.77% on average per year.
The Revenue is expected to grow by 1.96% on average over the next years.
EPS Next Y113.11%
EPS Next 2Y63.4%
EPS Next 3Y39.77%
EPS Next 5YN/A
Revenue Next Year-1.24%
Revenue Next 2Y1.04%
Revenue Next 3Y1.96%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FRVIA.PA Yearly Revenue VS EstimatesFRVIA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B 25B
FRVIA.PA Yearly EPS VS EstimatesFRVIA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.38, the valuation of FRVIA can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of FRVIA indicates a somewhat cheap valuation: FRVIA is cheaper than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. FRVIA is valued rather cheaply when compared to this.
FRVIA is valuated cheaply with a Price/Forward Earnings ratio of 3.46.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FRVIA indicates a rather cheap valuation: FRVIA is cheaper than 90.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. FRVIA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.38
Fwd PE 3.46
FRVIA.PA Price Earnings VS Forward Price EarningsFRVIA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than FRVIA, based on the Enterprise Value to EBITDA ratio.
FRVIA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FRVIA is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 2.48
FRVIA.PA Per share dataFRVIA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

FRVIA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FRVIA's earnings are expected to grow with 39.77% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y63.4%
EPS Next 3Y39.77%

0

5. Dividend

5.1 Amount

No dividends for FRVIA!.
Industry RankSector Rank
Dividend Yield N/A

FORVIA

EPA:FRVIA (7/4/2025, 7:00:00 PM)

9.304

-0.14 (-1.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)07-28 2025-07-28
Inst Owners35.67%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.83B
Analysts71.82
Price Target11.43 (22.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)-15.05%
DP-53.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.26%
PT rev (3m)-21.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE 7.38
Fwd PE 3.46
P/S 0.07
P/FCF 2.96
P/OCF 0.7
P/B 0.43
P/tB N/A
EV/EBITDA 2.48
EPS(TTM)1.26
EY13.54%
EPS(NY)2.69
Fwd EY28.86%
FCF(TTM)3.14
FCFY33.78%
OCF(TTM)13.35
OCFY143.48%
SpS136.86
BVpS21.78
TBVpS-27.64
PEG (NY)0.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -4.32%
ROCE 7.16%
ROIC 5.12%
ROICexc 6.87%
ROICexgc 26.32%
OM 4.56%
PM (TTM) N/A
GM 13.36%
FCFM 2.3%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
ROICexc(3y)6.19%
ROICexc(5y)5.9%
ROICexgc(3y)22.61%
ROICexgc(5y)20.29%
ROCE(3y)6.59%
ROCE(5y)6%
ROICexcg growth 3Y4.68%
ROICexcg growth 5Y-6.21%
ROICexc growth 3Y-2.68%
ROICexc growth 5Y-11.4%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.46
Debt/FCF 17.8
Debt/EBITDA 3.32
Cap/Depr 102.92%
Cap/Sales 7.46%
Interest Coverage 250
Cash Conversion 82.58%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.8
Altman-Z 1.14
F-Score4
WACC5.26%
ROIC/WACC0.97
Cap/Depr(3y)110.58%
Cap/Depr(5y)102.8%
Cap/Sales(3y)7.99%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.55%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%29.17%
EPS Next Y113.11%
EPS Next 2Y63.4%
EPS Next 3Y39.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-1.37%
Revenue Next Year-1.24%
Revenue Next 2Y1.04%
Revenue Next 3Y1.96%
Revenue Next 5YN/A
EBIT growth 1Y-3.18%
EBIT growth 3Y17.66%
EBIT growth 5Y0%
EBIT Next Year170.61%
EBIT Next 3Y46.67%
EBIT Next 5YN/A
FCF growth 1Y35.95%
FCF growth 3Y46.28%
FCF growth 5Y8.26%
OCF growth 1Y-0.3%
OCF growth 3Y23.48%
OCF growth 5Y8.09%